As expected, LAMA-84 CML cells treated with AQP5 siRNA showed a marked decrease in cell proliferation compared with cells treated with control siRNA (p<0.01) (Figure 4A). Here, AQP5 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.